HomeAGN • CNSX
add
Algernon Pharmaceuticals Inc
Previous close
$0.11
Day range
$0.10 - $0.11
Year range
$0.060 - $0.17
Market cap
2.73M CAD
Avg Volume
41.00K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Nov 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 353.01K | -29.83% |
Net income | -381.06K | 26.94% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -347.45K | 29.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Nov 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 357.92K | 382.60% |
Total assets | 3.65M | -7.51% |
Total liabilities | 1.87M | -36.48% |
Total equity | 1.79M | — |
Shares outstanding | 27.30M | — |
Price to book | 1.50 | — |
Return on assets | -23.23% | — |
Return on capital | -44.61% | — |
Cash Flow
Net change in cash
| (CAD) | Nov 2024info | Y/Y change |
|---|---|---|
Net income | -381.06K | 26.94% |
Cash from operations | -244.04K | -367.11% |
Cash from investing | — | — |
Cash from financing | 208.00 | — |
Net change in cash | -238.28K | -367.95% |
Free cash flow | -49.10K | -133.16% |
About
Founded
2015
Headquarters
Website
